It is the first oral Janus kinase (JAK) inhibitor indicated for acute treatment and maintenance therapy in both Crohn's disease and ulcerative colitis in adults.
Dr. Jeffrey Wilkinson of the South Saskatchewan Heart Clinic in Moose Jaw says it's too operationally and financially difficult to keep running under the public system.
To help prescribers initiate deprescribing processes, this internist designed an award-winning clinical decision support system that serves as a pioneer in this new area of expertise.